Xconomy National

Archives

by in

Entry	Author	Date	Location
OvaScience Uses Stem Cells to Revive Fertility	Arlene Weintraub	10/12/11	Boston
Big Pharma Attempts to Extend Own Lifespan by Activating Sirtuins	Steve Dickman	09/23/11	Boston
Three Kings: Bessemer, Greylock, Summit Raising Big New Funds	Gregory T. Huang	03/04/11	Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010	Gregory T. Huang	12/27/10	Boston
Glaxo Ends Resveratrol Drug Study	Ryan McBride	12/01/10	Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News	Rebecca Zacks	08/13/10	Boston
Christoph Westphal Resigns as Sirtris CEO, Takes Over Glaxo’s SR One Venture Arm	Ryan McBride	04/21/10	Boston
Alnara Bags $35M B Round, Plans to Seek FDA Approval for Cystic Fibrosis Drug	Ryan McBride	01/28/10	Boston
Xconomy Videos: Sirtris’ Westphal and Millennium’s Dunsire Talk Cures for Ills of Big Pharma	Ryan McBride	11/13/09	Boston
See You There Tomorrow at Pharma’s Bet on Boston Innovation	Luke Timmerman	11/03/09	Boston
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News	Rebecca Zacks	10/28/09	Boston
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes	Ryan McBride	10/14/09	Boston
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News	Ryan McBride	09/30/09	Boston
Sirtris’ Westphal and Collaborators Launching New Nonprofit to Help People Live Longer	Ryan McBride	09/24/09	Boston
Inside a Life Sciences Industry Confab: Notes from Convergence	Ryan McBride	06/17/09	Boston
The Health 2.0 Hub, Boston’s Secret Entertainment Cluster, A Path to Market for Energy Innovations, Dean Kamen, and more XSITEment	Robert Buderi	06/02/09	Boston
Elixir Raises $12 Million, Says Drug Trial Could Lead to Novartis Purchase	Roxanne Palmer	05/19/09	Boston
GSK biotech subsidiary Tempero Pharma launched in the Boston area	Ryan McBride	05/15/09	Boston
Bio Bigwigs from Boston and Beyond Gather in Cambridge to Discuss Future of Drug Development, Venture Capital, and Deals with Pharma	Ryan McBride	04/08/09	Boston
Magen BioSciences Sold for $14.5M, Codon Devices Closing Doors	Ryan McBride	04/03/09	Boston
Alnara Leapfrogs Into Phase III, Just Six Months After Getting Started	Ryan McBride	03/25/09	Boston
New Execs for Exact, Sirtris, and Ischemix; New Deal for Biogen and Aveo; New Money for MedAptus and Claros; & More Boston-Area Life Sciences News	Rebecca Zacks	03/25/09	Boston
Ex-Wyeth Exec Named Sirtris Pres.	Ryan McBride	03/20/09	Boston
The Greater Boston Diabetes Cluster	Ryan McBride	02/09/09	Boston
Viewers Hunt for Sirtris’ Anti-Aging Drugs After 60 Minutes Story	Ryan McBride	01/27/09	Boston
Vertex Stays Put, Hydra Handed $22M, Sequenom Still Pursuing Exact Sciences Acquisition, & More Boston-Area Life Sciences News	Rebecca Zacks	01/21/09	Boston
Hey Life Sciences Fans, Remember The Deals Back in 2008…	Ryan McBride	01/05/09	Boston
Novartis Deal Could Boost Ascent by $200M, Ariad’s Boardroom Drama Comes to Light, Targanta Takes Another Hit, & More Boston-Area Life Sciences News	Rebecca Zacks	12/10/08	Boston
Glaxo Promotes Sirtris’ Christoph Westphal to Drug Discovery Leadership Role	Luke Timmerman	12/03/08	Boston
Vertex Co-Founder’s Hedge Fund RA Capital Makes Waves in Biotech Industry with Former Harvard Grad Student at Helm	Ryan McBride	11/03/08	Boston
Page 1 of 2	next page »